Denali Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $79M | 5.5M | 14.52 |
| 2025-06-30 | $88M | 6.3M | 13.99 |
| 2025-03-31 | $92M | 6.8M | 13.60 |
| 2024-12-31 | $73M | 3.6M | 20.38 |
| 2024-09-30 | $109M | 3.7M | 29.13 |
| 2024-06-30 | $53M | 2.3M | 23.22 |
| 2024-03-31 | $14M | 687k | 20.52 |
| 2023-12-31 | $15M | 708k | 21.46 |
| 2023-09-30 | $13M | 643k | 20.63 |
| 2023-06-30 | $13M | 567k | 23.04 |
| 2023-03-31 | $13M | 567k | 23.04 |
| 2022-12-31 | $15M | 544k | 27.81 |
| 2022-09-30 | $16M | 530k | 30.69 |
| 2022-06-30 | $14M | 487k | 29.43 |
| 2022-03-31 | $14M | 435k | 32.17 |
| 2021-12-31 | $20M | 440k | 44.60 |
| 2021-09-30 | $22M | 435k | 50.45 |
| 2021-06-30 | $34M | 430k | 78.44 |
| 2021-03-31 | $17M | 298k | 57.10 |
| 2020-12-31 | $18M | 495k | 35.83 |
| 2020-09-30 | $18M | 495k | 35.83 |
| 2020-06-30 | $12M | 493k | 24.18 |
| 2020-03-31 | $1.2M | 66k | 17.51 |
| 2019-12-31 | $1.0M | 58k | 17.42 |
| 2019-09-30 | $917k | 60k | 15.32 |
| 2019-06-30 | $1.0M | 49k | 20.76 |
| 2019-03-31 | $691k | 30k | 23.22 |
| 2018-12-31 | $409k | 20k | 20.66 |
| 2018-09-30 | $320k | 15k | 21.74 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas